Described herein are novel compositions comprising a cannabis component selected from the group consisting of: a cannabinoid, a flavonoid and a terpenoid; and a protein, selected from the group consisting of whey and a plant protein. According to an embodiment, the cannabis component is non-covalently bound to the whey or to the plant protein. The plant protein may be selected from the group consisting of: soy protein, pea protein, rice protein, hemp protein, and hops protein or other plant derived protein.

The present disclosure relates to a composition including a Veronicastrum sibiricum L. Pennell extract (genus Veronicastrum) for prevention or treatment of inflammation, allergies, and asthma The Veronicastrum sibiricum L. Pennell extract (genus Veronicastrum) is useful as a pharmaceutical composition, health functional food, or health supplement food for prevention and treatment of inflammation, allergies, and asthma due to the confirmation, through various animal experiments, that a Veronicastrum sibiricum L. Pennell (genus Veronicastrum) extract exhibits excellent anti-inflammatory, anti-allergic and asthma-inhibitory activity, the animal experiments including: evaluation of inhibition of leukotriene production (Experimental Example 1); effects on the total number of cells in bronchoalveolar lavage (BAL) fluid by using male Balb/c mice (Experimental Example 2); effects on the number of neutrophil cells relative to the total number of cells in the BAL fluid (Experimental Example 3); effects on the number of Neutrophil+/Gr-1+ absolute cells in the BAL fluid (Experimental Example 4); effects on the number of CD11b+/Gr-1+ absolute cells from among lung cells (Experimental Example 5); effects on the number of CD4+/CD3+ absolute cells from among lung cells (Experimental Example 6); effects on the number of Macrophage+/CD11b+ absolute cells from among lung cells (Experimental Example 7); effects on the expression of inflammation factors in the BAL fluid (Experimental Example 8); and the like.

Disclosed herein are a composition comprising an Aucklandia lappa Decne. extract, especially a crude solvent extract from Aucklandia lappa as an active ingredient for alleviation, inhibition, prevention, or treatment of hair loss, and a preparation method therefor. The Aucklandia lappa Decne. extract can be used in a pharmaceutical or food composition useful for alleviating, inhibiting, preventing, and treating hair loss.

A pain relief composition has a base with cannabinoids in a range of 2% to 15% by weight of the pharmaceutical composition is present with ashwagandha extracts. Dimethyl sulfoxide (DMSO) in a range of 0.01% to 2% by weight of the pharmaceutical composition is further used. The cannaoids are one of cannabidiol (CBD) and tetrahydrocannabinol (THC).

A method of extracting at least one cannabinoid from a biomass comprises the following steps (i) contacting the biomass with a solvent formulation which comprises a C.sub.1-4 fluorinated hydrocarbon or a C.sub.1-4 hydrofluorocarbon ether, thereby to charge the solvent formulation with an extract from the biomass; and (ii) separating charged solvent formulation from the biomass.

The present invention relates to a process for preparation of Bakuchiol enriched psoralea extract substantially free of furanocoumarin impurities such as psoralen, isopsoralen and Bakuchicin and composition comprising the same. The process of the present invention uses unpulverized seeds of Psoralea genus of plants such as Psoralea corylifolia and employs novel single column chromatographic separation technique comprising silica gel and aluminium oxide columns clubbed to form single column to obtain a bakuchiol composition which is substantially free of furanocoumarin impurities. The bakuchiol composition is effective for prevention, alleviation, reduction, or treatment of post inflammatory hyper pigmentation (PIH) without any side-effects such as potential phototoxicity, topical irritation, carcinogenicity, and reproductive toxicity associated with furanocoumarin impurities.

A process for controlling a decarboxylation of acidic cannabinoids for an infused soluble fat product, such as a butter product, is disclosed. In one embodiment for producing a butter product, raw cannabis base material is dried, pulverized, heated, and cooled to produce a decarbed cannabis material. The decarbed cannabis material is mixed with unsalted butter in an about 22:1 to and about 26:1 ratio, by weight, at ambient temperature and pressure, to produce a heterogenous butter material. The heterogenous butter material is canned and subjected to in-container thermal processing, including agitation during the thermal processing. The resulting heterogenous butter material is separated before cooling produces the butter product.

The invention relates to a THC-free cannabinoid concentrate, method of obtaining the same and use thereof. The method of obtaining comprises an alkaline wash to purify lipid extracts.

A Syringa microphylla seed extract includes the following components by weight based on a total weight of the Syringa microphylla seed extract: 0.4944-0.7142 mg/g of echinacoside, 6.624-7.617 mg/g of oleuropein, 0.4276-0.6309 mg/g of verbascoside, 3.927-4.684 mg/g of syringin, and 4.505-5.250 mg/g of forsythiaside B. A method of preparing the Syringa microphylla seed extract is disclosed. A composition for treating antibiotic-resistant infections that includes the Syringa microphylla seed extract is also disclosed.

A process for controlling a decarboxylation of acidic cannabinoids for an infused soluble fat product, such as a butter product, is disclosed. In one embodiment for producing a butter product, raw cannabis base material is dried, pulverized, heated, and cooled to produce a decarbed cannabis material. The decarbed cannabis material is mixed with unsalted butter in an about 22:1 to and about 26:1 ratio, by weight, at ambient temperature and pressure, to produce a heterogenous butter material. The heterogenous butter material is canned and subjected to in-container thermal processing, including agitation during the thermal processing. The resulting heterogenous butter material is separated before cooling produces the butter product.